✅ Model Answer:
• Diagnosis: Celiac disease with dermatitis herpetiformis.
• Evidence: Positive anti-tTG IgA (>10x upper normal), IgA deposition in dermal papillae on skin biopsy, characteristic vesicular rash on elbows/knees, chronic diarrhea, poor growth.
• Next step: Start lifelong gluten-free diet. Consider dapsone for pruritus (short-term) if severe rash. Monitor nutritional deficiencies and growth.

✅ Model Answer:
• Definition: A cutaneous manifestation of celiac disease (gluten-sensitive enteropathy).
• Mechanism: IgA antibodies (anti-tTG and anti-epidermal transglutaminase) are deposited in the dermal papillae, leading to neutrophil infiltration and vesicle formation.
• Genetics: Strongly associated with HLA-DQ2 and HLA-DQ8 (same as celiac disease).
• Prevalence: Affects ~10-15% of patients with celiac disease.
• Rash: Intensely pruritic, vesicular, and bullous lesions, typically on extensor surfaces (elbows, knees, buttocks, scalp).
• Gluten dependency: Rash improves with gluten-free diet; flares with gluten ingestion.

✅ Model Answer:
• Skin features:
- Intensely pruritic vesicular rash: Small vesicles and bullae.
- Distribution: Elbows, knees, buttocks, scalp, and back (extensor surfaces).
- Excoriations: Due to intense itching (often crusted, healing with hyperpigmentation).
- Symmetrical.
- Blisters: Often ruptured by scratching, leaving erosions.
• GI features:
- Chronic diarrhea, steatorrhea.
- Failure to thrive.
- Abdominal distension.
- Poor growth.
• Other: Iron deficiency anemia, vitamin deficiencies, osteoporosis (if untreated).

✅ Model Answer:
• Skin biopsy:
- Direct immunofluorescence: Granular IgA deposition in the dermal papillae (pathognomonic).
- Hematoxylin-eosin: Subepidermal vesicles, microabscesses, and neutrophilic infiltrate.
• Serologic tests:
- Anti-tTG IgA: Positive (highly sensitive and specific).
- Anti-EMA IgA: Positive.
- Total IgA: To rule out IgA deficiency.
• Small bowel biopsy: May show villous atrophy (Marsh 3) in 70-80% of patients, even without GI symptoms.
• Rule out other causes: Normal fecal elastase, normal sweat chloride.
• Genetic testing: HLA-DQ2/DQ8 (supportive).

✅ Model Answer:
• Lifelong gluten-free diet:
- Avoid: Wheat, barley, rye.
- Rash improvement: Usually improves within weeks to months, but may take 1-2 years for complete resolution.
- GI symptoms: Improve similarly.
• Dapsone:
- Indication: For severe pruritus or while awaiting response to gluten-free diet.
- Dose: 1-2 mg/kg/day (usual adult dose 50-100 mg/day).
- Monitor: CBC (methemoglobinemia, hemolysis), liver function tests.
- Wean: Dapsone can be tapered after gluten-free diet is established and rash improves.
• Nutritional support:
- Iron, calcium, vitamin D, B12, folate, zinc.
- Monitor growth and bone health.
• Dermatology and gastroenterology follow-up.

✅ Model Answer:
• Same as celiac disease:
- Iron deficiency anemia.
- Osteoporosis, osteopenia.
- Vitamin B12, folate, vitamin D deficiencies.
- Growth failure, delayed puberty.
- Autoimmune diseases: Type 1 diabetes, thyroiditis, autoimmune hepatitis.
- Intestinal lymphoma (EATL) – rare.
- Small bowel adenocarcinoma.
• Skin-related:
- Scarring and post-inflammatory hyperpigmentation.
- Bacterial superinfection (if excoriated).
- Dapsone side effects: Methemoglobinemia, hemolytic anemia, agranulocytosis.
• Psychosocial: Impact of chronic rash and dietary restrictions.

✅ Model Answer:
• Prognosis:
- Excellent with strict gluten-free diet.
- Rash: Usually resolves with gluten-free diet (may take 1-2 years).
- Dapsone: Can be weaned off after several months.
- GI symptoms: Improve with gluten-free diet.
- Growth: Catch-up growth with adequate nutrition.
- Complications: Rare if strict gluten-free diet is maintained.
• Long-term follow-up:
- Monitor anti-tTG IgA: Every 6-12 months.
- Monitor growth.
- Monitor nutritional status.
- Screen for associated autoimmune diseases.
- Family screening: First-degree relatives should be screened for celiac disease.
- Dermatology follow-up: For rash management.

✅ Model Answer:
• Skin biopsy: The definitive diagnostic test for dermatitis herpetiformis.
• Direct immunofluorescence:
- IgA deposition: Granular IgA in the dermal papillae (pathognomonic).
- Fibrin deposition: Often present.
- Complement (C3): May be present.
• Hematoxylin-eosin:
- Subepidermal vesicle formation.
- Microabscesses.
- Neutrophilic infiltrate.
• Importance:
- Confirms diagnosis in patients with a vesicular rash and positive celiac serology.
- Differentiates from other vesicular rashes (e.g., bullous pemphigoid, linear IgA disease).
• Monitoring: Skin biopsy is not used to monitor disease activity; clinical improvement is the main indicator.